[HTML][HTML] Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics
HN Lee, B Xu, AP Lewkowicz, K Engel… - …, 2024 - thelancet.com
Background Ebola virus disease (EVD) survivors experience ocular sequelae including
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
[HTML][HTML] Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics
HN Lee, B Xu, AP Lewkowicz, K Engel, L Kelley-Baker… - eBioMedicine, 2024 - Elsevier
Background Ebola virus disease (EVD) survivors experience ocular sequelae including
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
[HTML][HTML] Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics
HN Lee, B Xu, AP Lewkowicz, K Engel… - eBioMedicine, 2024 - ncbi.nlm.nih.gov
Background Ebola virus disease (EVD) survivors experience ocular sequelae including
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
[引用][C] Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics
HN Lee, B Xu, AP Lewkowicz, K Engel, L Kelley-Baker… - EBioMedicine, 2024 - osti.gov
Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics
HN Lee, B Xu, AP Lewkowicz, K Engel… - … - pubmed.ncbi.nlm.nih.gov
Background Ebola virus disease (EVD) survivors experience ocular sequelae including
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics.
HN Lee, B Xu, AP Lewkowicz, K Engel… - Ebiomedicine, 2024 - europepmc.org
Background Ebola virus disease (EVD) survivors experience ocular sequelae including
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …